Screener
Amneal Pharmaceuticals, Inc. AMRX Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s current debt?
- Amneal Pharmaceuticals, Inc. (AMRX) reported current debt of $5.96M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s current debt changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s current debt decreased by 80.9% year-over-year, from $31.18M to $5.96M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s current debt?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s current debt has grown at a -31.3% compound annual growth rate (CAGR), from $44.23M to $6.76M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Amneal Pharmaceuticals, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude